Visual Attention in Children With Migraine: The Importance of Prophylaxis.
This study aimed to compare the visual attention performance of children newly diagnosed with migraine, children undergoing migraine prophylaxis, and a healthy control group. Eighty-two children aged 8 to 12 years were divided into 3 groups: untreated migraine (n = 30), migraine prophylaxis (n = 22), and control (n = 30). All were subjected to a visual attention assessment with the Trail Making Test parts A and B, Letter-Cancellation Test, and the Brazilian Visual Attention Test 3rd edition. Although performance in attention tasks was within the normal range in all groups, children with untreated migraine performed significantly worse in some visual attention tests than did the control children or children undergoing migraine prophylaxis. The migraine prophylaxis group performed as well as the control group. The deregulation of the neurochemical mechanisms underlying the physiopathology of migraine might induce visual attention deficits, but an effective prophylactic treatment might reverse migraine symptoms.
Division of Investigation and Treatment of Headaches (DITH), Department of Neurology and Neurosurgery Federal University of São Paulo, UNIFESP, São Paulo, Brazil cvdiniz@terra.com.br.
Thaís Rodrigues
TR
Villa
Division of Investigation and Treatment of Headaches (DITH), Department of Neurology and Neurosurgery Federal University of São Paulo, UNIFESP, São Paulo, Brazil.
Larissa M
LM
Agessi
Division of Investigation and Treatment of Headaches (DITH), Department of Neurology and Neurosurgery Federal University of São Paulo, UNIFESP, São Paulo, Brazil.
Andréa R C
AR
Moutran
Division of Investigation and Treatment of Headaches (DITH), Department of Neurology and Neurosurgery Federal University of São Paulo, UNIFESP, São Paulo, Brazil.
Alberto A
AA
Gabbai
Division of Investigation and Treatment of Headaches (DITH), Department of Neurology and Neurosurgery Federal University of São Paulo, UNIFESP, São Paulo, Brazil.
Deusvenir de S
Dde S
Carvalho
D001289:Attention Deficit Disorder with Hyperactivity / Q000209:etiology* / Q000517:prevention & control; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000150:complications* / Q000188:drug therapy; D009483:Neuropsychological Tests; D012189:Retrospective Studies; D014665:Vasodilator Agents / Q000627:therapeutic use; D014786:Vision Disorders / Q000209:etiology* / Q000517:prevention & control
D014665:Vasodilator Agents
children; migraine; prophylaxis; visual attention